Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 Pentyne 1 ol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113666800B details a scalable synthesis method for 4-pentyne-1-ol offering high purity and reduced liquid ammonia usage for reliable pharmaceutical intermediate supply chains.
Patent CN104193601A reveals a safer one-pot oxidation-dehydration route for 3-methyl-2-penten-4-yn-1-al, offering significant cost reduction and supply chain reliability for vitamin A precursors.